1. Home
  2. ACIU vs ALCO Comparison

ACIU vs ALCO Comparison

Compare ACIU & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIU
  • ALCO
  • Stock Information
  • Founded
  • ACIU 2003
  • ALCO 1960
  • Country
  • ACIU Switzerland
  • ALCO United States
  • Employees
  • ACIU N/A
  • ALCO N/A
  • Industry
  • ACIU Biotechnology: Pharmaceutical Preparations
  • ALCO
  • Sector
  • ACIU Health Care
  • ALCO
  • Exchange
  • ACIU Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • ACIU 247.4M
  • ALCO 230.7M
  • IPO Year
  • ACIU 2016
  • ALCO N/A
  • Fundamental
  • Price
  • ACIU $1.77
  • ALCO $29.93
  • Analyst Decision
  • ACIU Strong Buy
  • ALCO
  • Analyst Count
  • ACIU 2
  • ALCO 0
  • Target Price
  • ACIU $12.00
  • ALCO N/A
  • AVG Volume (30 Days)
  • ACIU 185.3K
  • ALCO 50.8K
  • Earning Date
  • ACIU 05-12-2025
  • ALCO 05-05-2025
  • Dividend Yield
  • ACIU N/A
  • ALCO 0.65%
  • EPS Growth
  • ACIU N/A
  • ALCO N/A
  • EPS
  • ACIU N/A
  • ALCO N/A
  • Revenue
  • ACIU $30,136,397.00
  • ALCO $49,552,000.00
  • Revenue This Year
  • ACIU N/A
  • ALCO $22.90
  • Revenue Next Year
  • ACIU $680.74
  • ALCO N/A
  • P/E Ratio
  • ACIU N/A
  • ALCO N/A
  • Revenue Growth
  • ACIU 84.51
  • ALCO 14.59
  • 52 Week Low
  • ACIU $1.77
  • ALCO $24.14
  • 52 Week High
  • ACIU $4.98
  • ALCO $34.08
  • Technical
  • Relative Strength Index (RSI)
  • ACIU 25.49
  • ALCO 54.06
  • Support Level
  • ACIU $1.77
  • ALCO $29.05
  • Resistance Level
  • ACIU $2.05
  • ALCO $31.05
  • Average True Range (ATR)
  • ACIU 0.12
  • ALCO 0.89
  • MACD
  • ACIU -0.02
  • ALCO 0.16
  • Stochastic Oscillator
  • ACIU 0.00
  • ALCO 55.20

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: